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ABSTRACT 
Ethical issues related the responsible conduct of research involve questions concerning 
the rights and obligations of investigators to propose, design, implement, and publish 
research. When a principal investigator (PI) transfers institutions during a grant cycle, 
financial and recognition issues need to be addressed to preserve all parties’ obligations 
and best interests in a mutually beneficial way. Although grants often transfer with the 
PI, sometimes they do not. Maintaining a grant at an institution after the PI leaves does 
not negate the grantee institution’s obligation to recognize the PI’s original ideas, 
contributions, and potential rights to some forms of expression and compensation. 
Issues include maintaining a role for the PI in determining how to take credit for, share 
and publish results that involve his or her original ideas. Ascribing proper credit can 
become a thorny issue. This paper provides a framework for addressing situations and 
disagreements that may occur when a new PI continues the work after the original PI 
transfers. Included are suggestions for proactively developing institutional mechanisms 
that address such issues. Considerations include how to develop solutions that comply 
with the responsible conduct of research, equitably resolve claims regarding reporting of 
results, and avoid the possibility of plagiarism.  
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INTRODUCTION    
A grant award is a significant, positive event for the principal investigator (PI), co-
investigators, other laboratory members, sponsoring department and sponsoring 
institution. The award may represent years of effort and discovery on the PI’s part—and 
obtaining the award is often predicated on how promising a review board deems the 
PI’s preliminary data and original ideas to be.  
 
Despite how heavily vested the PI is in the institution and the research funded by the 
grant, the PI might move to a different institution during the funding period, for a number 
of reasons. These may include perceived personal or career growth opportunities for 
the PI, such as career advancement, salary increases, or a potentially more productive 
scientific environment. The career needs of the PI’s domestic partner may drive the 
decision. The PI’s fixed-duration employment contract may expire, or the PI may 
regrettably fail to obtain the institution’s required academic advancement.  
 
Regardless of the reason, when a move occurs, one might assume that the awarded 
grant would transfer with the PI. While that often happens, it is not categorically the 
case. If a PI transfers to another facility during the course of that grant-funded research, 
transfer of the funds, plus his or her ownership of original ideas can pose multiple 
challenges. Understanding all the stakeholders, as well as the legal and ethical 
implications of transfers, can help facilitate decisions that are in the best interest of 
everyone involved. 
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Legal precedent (Stanford v. Roche, 2011; CGR 2011a), grant provisions (NIH 2010a; 
State of California 2014), and institutional policies often stipulate that the financial award 
for most grants is the property of the institution to which the grant is awarded. However, 
transfer or retention of funds is only one aspect of the equation. Although discoveries 
stemming from work as an employee or faculty member normally are either shared or 
assigned entirely to the host institution as a condition of employment (nolo.com), such 
issues can become murky when a PI transfers, particularly if the grant remains with the 
grantee institution. Thus, ownership of original ideas, authorship of published results, 
and potential claims regarding patents resulting from that research need to be 
addressed before a transfer occurs.  
 
To date, little has been written about the ethical and legal issues surrounding grant/PI 
transfers. This article seeks to fill that gap by suggesting how institutions can define 
principles and establish processes to avoid or address conflicts that may arise among 
the parties involved with a funded grant when the PI moves. This article introduces the 
typical grant and its stakeholders, then examines decisions related to transferring, 
retaining, or terminating a grant. Issues regarding publication of results when grants are 
not transferred are also examined.  
 
THE GRANT AND ITS STAKEHOLDERS 
The grant 
In this article, a grant is defined as any award of monies to support research or scholarly 
endeavors. Grant monies may originate from for-profit or non-profit entities, state or 
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federal agencies. This article concentrates on federal grants to universities; however, 
the principles described herein should apply to most non-federal grants also.  
 
Grant monies fund both direct and indirect costs for a research project. Direct funds 
support the investigative team’s salary, equipment, and other expenses linked solely to 
the performance of the research specified in the awarded grant. Indirect funds support 
infrastructure needed to undertake such activities including facilities and administrative 
costs. Such items cannot be linked solely to the research project. Indirect amounts 
generally are calculated as a fraction of the direct award amount. For most federally 
funded grants, the cost for indirect support ranges from 50% to 70% of the direct 
amount (GAO 2013). As indirect funds are intended to support research infrastructure in 
general, they can be a very beneficial source of revenue for an institution. 
 
Grants may also be classified based upon the principal investigator’s role in the genesis 
of the grant. Grants that involve the principal investigator’s novel ideas, with or without 
additional input from others, are termed investigator-initiated grants. Investigator-
initiated grant applications are generally assessed through a multistep peer review 
process and are awarded only to the highest-scored applications (NIH n.d.).  
 
In contrast, non-investigator initiated grants are more like a fee-for-service arrangement 
(such as grants to participants in an industry-sponsored pharmaceutical trial). 
Alternatively, awards to center cores for carrying out a larger grant like a Research 
Program and Center Grant (termed P30 grants by the NIH) may arguably have 
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components of both non-investigatorinitiated and investigatorinitiated grants (NIH 2013). 
Principal investigators on non-investigator initiated grants generally have little or no 
claim to the grant or its research results. This manuscript focuses on investigator-
initiated grants. 
 
The stakeholders 
The sponsor/funding agency 
Grants are subject to the rules that their sponsor(s) or parent organization(s) set forth. 
Sponsors look to fund grant applications that most closely match the funding agency’s 
scope of interest (NIH n.d.). For example, the National Institutes of Health (NIH) is the 
major sponsor of federally funded, investigator-initiated research in the U.S. NIH 
provided nearly $30.1 billion dollars for research in 2014 (NIH 2015), which represents 
the second-highest outlay of R&D monies in the federal budget (Sargent 2013).  
 
Globally, any funding agency’s policy and the particular grant may determine, or at least 
strongly influence, what happens if the PI changes institutions. For example, state-
sponsored awards may require that funded research take place at an institution within 
the state. Thus, if the PI were to move to an out-of-state institution, the grant would not 
transfer. Similarly, grants that support enhanced research infrastructure at an institution 
(such as NIH’s G-series grants) (NIH 2013), are generally retained by the institution to 
which they were awarded. In contrast, grants awarded to help develop the careers of 
researchers with high potential (such as NIH’s K-series grants) generally move with the 
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PI (NIH 2010a). While general criteria exist regarding grant transferability, additional 
criteria usually are specified when grant applications are solicited. 
 
The grantee (host) institution 
Grants typically are awarded to an institution (such as a university or non-profit research 
institute) on behalf of the PI—not to the PI. Federal grant monies are the major means 
of financial support for research efforts at most U.S. institutions and abroad (Sargent 
2013; Zinner 2009). The grantee institution’s two-fold role is to (1) maintain an 
environment in which the research can succeed and (2) provide fiscal oversight for the 
grant, including accountability for its direct costs and indirect expenses (GAO 2013; 
CGR 2001). 
 
The principal investigator (PI) 
The PI is generally a faculty member at the host institution; he or she oversees the 
grant. For investigator-initiated grants, the PI is usually the individual who generated the 
major ideas, research methods/design, and/or did (or oversaw) the majority of the 
intellectual, experimental and organizational work that led to the successful grant award.  
 
Other potential stakeholders 
Co-investigators are other faculty involved with the grant. They may be staff at the host 
institution or other institutions. They may contribute ideas, techniques or other expertise 
that are essential to successfully executing part of the research project. Based on their 
 9  
 
roles, co-investigators may have a reasonable argument for continued involvement in 
and financial support from the grant if a transfer is contemplated.  
 
Laboratory personnel are non-faculty scientists, fixed-duration contract researchers, and 
trainees (such as graduate students and post-doctoral fellows) who work under the PI(s) 
and co-investigator(s). Lab personnel generally do not have leadership roles in a grant 
but may expect compensation and mentoring that the grant supports. Lab personnel 
may transfer institutions with a PI; however, they may or may not continue to be 
supported by a grant, depending on whether it is retained in whole or in part, or is no 
longer associated with the same PI.  
 
GRANT DISPOSITION WHEN THE PI LEAVES THE INSTITUTION: PROCESSES 
AND PERSPECTIVES 
Compliance to a grant’s stipulations encompasses both management of funds awarded 
as well as the conduct of science (CGR 2001). Thus, each grant is subject to special 
considerations when a PI leaves an institution before a grant cycle is finished. 
Additionally, all federally funded research must be compliant with the Bayh-Dole Act, 
which identifies a duty of the funded investigators and institution to facilitate results 
(including inventions) be made commercially available to benefit the public (CGR 
2011b; Henderson 2002). 
 
Financial Interests 
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When a PI on an investigator-initiated grant moves, he or she may seek transfer of the 
grant to the new (“gaining”) institution while the original institution may seek to retain it. 
Although the onus is on the PI to start the paperwork that requests a grant transfer (NIH 
2010a), all parties involved must provide justification for where the grant should “live.” A 
host institution wishing keep a grant needs to formally identify a faculty member who 
would become the new PI and file a request for that with the grant’s sponsor. Conflict 
may arise when opinion differs regarding who will continue to be the PI or whether the 
grant should transfer.  
 
It is almost always in the funding agency’s best interests to continue the grant if it will 
still further the agency’s goals and the proposed project can be completed. Where the 
project is completed may be a matter of debate.  
 
Grant Transfer and Completing the Proposed Projects  
A number of scenarios might influence the appropriateness of transferring a grant or 
retaining it at the original institution. The funding agency and all other parties involved in 
the grant’s disposition should consider all of the following. (1) If the grant were to be 
retained at the initial institution, would the new PI and team be able to successfully 
complete the proposed work? (2) Similarly, if the PI were to maintain the grant at a new 
institution, would the new team and institution be able to complete the work? (3) Does 
the gaining institution have the infrastructure and resources needed to accomplish the 
grant’s research goals? (4) Does that infrastructure include the ability to comply with 
needed protections of research subjects if applicable? (5) Do human subject protections 
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differ between institutions; and, if so, do those differences run the risk of patient harm or 
weakening study endpoints?  
 
An institution might seek to retain grant funding not only for the prestige of having 
promising research be attributed to their institution, but also for financial reasons. Grant-
funded equipment often remains with the host institution unless the sponsor deems that 
the research cannot continue at the new institution without it (NIH 2010b). More 
importantly, funds for indirect costs can help support a variety of ongoing research 
efforts: by providing monies to support infrastructure, equipment and personnel. This 
support may help prevent attrition of research-associated faculty, and help support post-
doctoral trainees and others who contribute to the host institution’s overall research 
mission, which in turn indirectly facilitates future grant awards (GAO 2013). Also, 
because of the capital deposit at the beginning of the research cycle, grant awards may 
improve an institution’s financial liquidity and stability. Such payments may enhance the 
institution’s capacity to offer recruitment packages and capital outlays. Furthermore, 
academic rankings of research-focused schools, universities, and similar institutions are 
based, in part, on total extramural institutional funding (particularly that given for 
investigator-initiated research, such as NIH RO1s) (NIH 2013).  
 
Ultimately, research and innovation fuel economic growth (Henderson 2002; Atkinson 
2011)—and some potential income for universities if discoveries turn into licensing 
opportunities with industries (Stanford v. Roche 2011; CGR 2011a; NIH 2010a; Mangan 
2000). Finally, government funding has been stagnant or declining in recent years 
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(Sargent 2013; Atkinson 2011; Browning 2014). This adds pressure to administrators at 
all levels to retain grant monies. Thus, every research institution seeks to maintain or 
increase its total grant dollars.  
  
Despite all those reasons for an institution to want to retain a grant, legitimate reasons 
exist for allowing a grant transfer. First, a research institution plays a critical societal role 
as a guardian of ideas (Lawrence 1990), as well as a servicer of information exchange 
(CGR 2011a; Faust 2010). Because research institutions are part of the larger society, it 
is common for researchers to change institutions. Indeed, universities frequently seek to 
recruit new faculty with records of stellar grant funding. Thus, recruiting institutions are 
interested in grants moving relatively freely with faculty PIs. Because the same 
institutions will predictably be both originating and transfer institutions, it may be in their 
long-term interests to accommodate a request to relinquish a grant when the PI moves. 
 
Recognition-based Interests 
When a grant is transferred, both financial and recognition-based interests are 
potentially at stake. Issues surrounding the latter are elucidated in the principles of 
responsible conduct of research set forth by the Office of Research Integrity 
(http://ori.hhs.gov/) and the International Committee of Medical Journal Editors (ICMJE; 
http://www.icmje.org/recommendations/). 
 
These principles are widely accepted among academic groups and research institutions 
as standards for conducting research and publishing its results. Publishing guidelines 
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are detailed in ICJME’s Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals (ICJME 1991; Uniform Reqs 2010). More details and real-world applications of 
those guidelines can be found in the latest edition of Shamoo and Resnik’s Responsible 
Conduct of Research (Shamoo 2009). 
 
The ethical conduct of research principles and terms of most investigator-initiated grants 
generally obligate the PIs to publish their results (e.g., in poster presentations, peer-
reviewed journals). Authorship on publications and in public presentations is reserved 
for those who are responsible for, and deserve credit for, the work. Specifically, authors 
are those who (1) make substantial contribution to the concept and design of the work, 
(2) draft the work or revise it critically for intellectual content, (3) approve the final 
version to be published, and (4) agree to be accountable for all aspects of the work 
(ICJME n.d.). Thus, for grants that involve novel ideas, all parties who are active 
members at the concept and design stage should be involved in reporting research 
results in any format. Furthermore, the ICMJE states that individuals with a substantial 
role in the conceptualization and generation of the ideas around a publication should be 
allowed the opportunity to participate in the research project. Thus it is improper to 
exclude such individuals from steps 2 through 3. However, when a PI leaves and the 
grant remains with the grantee institution, that institution’s and other investigator’s 
obligation to ensure the continued involvement of the PI in publications varies, 
depending on the extent to which the results embody the original PI’s original ideas.  
 
When interests clash 
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If research conducted by the new PI closely follows that of the original PI’s ideas, 
ethically, the original PI should be actively involved in the grant’s ongoing research and 
its subsequent publication—and duly acknowledged for his or her role in the discovery 
of those ideas. Periodic communications between PIs can ensure that both forms of 
involvement occur appropriately. If the grant’s focus changes under the new PI so that 
the results reflect the examination of new questions distinct from those posed by the 
original PI, the claim for involvement of the first PI is much weaker. 
 
Philosophical differences may arise regarding what constitutes proper versus improper 
use of the original PI’s words and ideas (Bouville 2008). This begs the question of what 
constitutes plagiarism, which is misuse of large amounts of someone else’s material in 
such a way that would mislead most readers as to the listed author’s contribution. The 
Office of Research Integrity defines plagiarism as “theft or misappropriation of 
intellectual property and the substantial unattributed textual copying [ver batim, or nearly 
so] of another’s work” (ORI 1994). Because of this, the Council on Governmental 
Relations and others recommend that research centers proactively develop policies to 
address “who owns what” in the event of a grant transfer, so that disputes may be 
resolved equitably to ensure fair recognition of the intellectual roles of all contributors 
(CGR 2011b; Harper 2007). The simplest way to avoid plagiarism is by including the 
original PI as an author throughout the writing and publication process. 
 
A third point of contention with recognition is ownership of patents. As long as the 
grantee institution abides by the provisions of the Bayh-Dole Act (amended in 2000 by 
the Technology Transfer Commercialization Act) (Stanford v. Roche 2011), the grantee 
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institution has the right to retain title to any invention conceived or first brought into 
practice using federal grant funds (NIH 2010a). In this sense, the first PI would be the 
“author/creator” and “custodian” of the ideas, processes, devices, organisms and/or 
data conceived and developed—and may be named as an inventor on any patent that 
emerges from that. But the grantee institution owns the results of the PI’s efforts. (On 
occasion, co-investigators and key lab personnel may also have a right to participate in 
patent applications, subject to contract-based employment verbiage regarding 
discoveries.)  
 
PROPOSED SOLUTIONS  
In the vast majority of grants, the host institution will agree to transfer a grant to the PI’s 
new institution. In instances where that institution seeks to retain the grant, one of two 
scenarios may transpire. Rarely, a grant may move in a significantly different direction 
than the original PI delineated. In that case, involvement of, and agreement by, the 
original PI may not be required. However, in the more common scenario, research 
under the grant continues under a new PI but relies on the first PI’s original ideas. For 
this latter scenario, we propose a four-pronged strategy: 
(1) Develop processes and procedures to address such issues if they are not already in 
place (described in the following paragraphs); invoke when needed. 
(2) Incorporate all stipulations of the grant in considering any disputes.    
(3) Foster open dialogue among all stakeholders working on the grant.  
(4) As needed, solicit input from an impartial third party, such as an ethics committee. 
 
Proactive policy development 
 16  
 
While most institutions have clauses in their conditions of employment regarding 
assignment of inventions, many do not have policies regarding the topics discussed in 
this paper. As a starting point, the granting agency’s goals and objectives must be 
defined and understood, including the range of solutions that permit continued grant 
funding.   
 
Importantly, institutional policies and procedures need to be clearly defined and in place 
(Browning 2014) before disputes arise. These should be created through a structure 
that includes input from faculty (such as special oversight committees set up by school 
councils or university senates) as well as senior institutional leadership. In addition to 
defining issues regarding retention or transfer of grants, the role of the original vs. new 
PI in reporting results should be defined explicitly as part of any transfer arrangement. 
Also, issues of scholarship, authorship, recognition and shared compensation (if 
royalties or licensing are involved) need to be addressed.  
 
Thus, a major task for any oversight committee is to determine the degree to which the 
research—at any particular time—is intertwined with the PI’s original ideas. Answering 
that question can generate scenarios to identify under what circumstances the grant 
would be continued and what recognitions would be appropriate for all parties involved. 
Ideally, the university should recognize the first PI’s key intellectual role in developing 
the ideas embodied in the funded research. As already noted, any resolution that does 
not recognize that PI’s original ideas and allow him or her significant input in reporting 
 17  
 
those ideas is problematic with respect to responsible conduct of research principles 
and the potential for plagiarism.  
 
Grant termination is a last resort if all involved parties cannot agree on direction and/or 
responsibilities. Any attempt to publish a highly contested work among contributors who 
have conflicting points of view will range from problematic to impossible. With the 
suggestions presented in this article, grantee institutions should be able to delineate 
acceptable solutions. 
 
Grant stipulations 
In addition to what has already been discussed about understanding grant stipulations, 
the following general tenets apply. Disputes over fee-for-service grants likely will be 
resolved by the sponsor, in consultation with the institution and/or the original PI. 
Disputes over investigator-initiated grants may require any combination of our four listed 
strategies. 
 
Open dialogue 
Good communication among all parties involved is key. Foster formal, open dialogue 
among the original PI, other investigators (particularly those whose activities were 
essential in obtaining the award), and departmental/institutional representatives. 
Encourage everyone to articulate their interests and perspectives on what options would 
best help achieve the grant’s objectives. Clearly define expectations regarding work in 
progress, oversight of future work and authorship of that work, as well as the best ways 
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to communicate among all vested parties (such as in regular Skype meetings, periodic 
e-mail updates, and so on). 
 
Ethics committee involvement 
Soliciting input from an impartial third party, such as an ethics committee, can help 
clarify even the thorniest problems and provide insights regarding direction, authorship 
and other issues as needed. Not intended to be a last resort but rather a dispassionate 
authority, an ethics committee can weigh the facts and chart a clear course through 
murky waters. An ethics committee is a valuable but underused resource for such 
situations. 
 
CONCLUSIONS 
Grant transfers can present unexpected challenges. To avert problems, minimize 
disputes and ensure that everyone’s interests are best served, we propose that 
institutions develop guidelines and processes, based on standards identified in the 
ethical conduct of research and ICJME publication guidelines. These guidelines should 
help resolve three distinct issues: future financial support under a grant, 
control/recognition of the original ideas embodied in the grant, and 
expression/protection of the faculty member’s right to academic freedom. We suggest 
the invocation of an institutional ethics or other oversight group, staffed in part or in 
whole by faculty, which can operate in tandem with administration (and the funding 
agency, if needed), to help resolve disputes at any level. 
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